RE:FundIt seems Dalsin and Greene may have effectively sold a large percentage of their PHM holdings into hype about a year-end EBITDA and sales run-rate based significantly upon LOIs yet to close and a bottom line we've yet to see. They also played to cross-selling opportunity feeding into limited PHM history. What we need to see as investors is the bottom line profitability of Sleep Management, and the LOIs, not just talk about sales and EBITDA. This will be some time yet in coming given the accounting cycle. We also need to see how the competion may respond.
Will the fund even hold all of its PHM shares by the time we see the bottin line profitability of the year-end run-rate they have talked up. Also are Dalsin and Greene running for cover ahead of election risk in the US.